Hjem › Myositt › Florida › Miami
Kliniske studier for Myositt i Miami, FL
4 studier for Myositt søker deltakere på steder i og rundt Miami (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
RekruttererFase 3
- University of Miami, Miami
- University of Miami Dermatology Clinical Trials Unit, Miami
- University of Miami, Miami
- og 1 flere
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RekruttererFase 2
- Artiva Investigational Site Miami, Miami
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RekruttererFase 1
- Nicklaus Children's Hospital, Miami
Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
RekruttererFase 2/3
- Bioresearch Partner, Miami
Myositt-studier i andre byer
- Durham, NC10 studier
- New York City, NY6 studier
- Chicago, IL6 studier
- Boston, MA6 studier
- Houston, TX5 studier
- Cedar Rapids, IA4 studier
- Orange, CA3 studier
- Dallas, TX3 studier
- Charlotte, NC3 studier
- Ann Arbor, MI3 studier
- Gainesville, FL3 studier
- Plantation, FL3 studier
Andre studier i Miami
- Brystkreft42 studier
- Kreft (alle typer)36 studier
- Ikke-småcellet lungekreft31 studier
- Prostatakreft27 studier
- Fedme27 studier
- Akut myelogen leukemi24 studier
- Metastatisk kreft24 studier
- Eggstokkreft23 studier
- Overvekt23 studier
- Multipelt myelom21 studier
- Ulcerøs kolitt21 studier
- Alzheimers sykdom20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.